| Cora Health | 61.2 | 2 | 2 |
| Information Retrieval | 60.0 | 6 | 0 |
| Inflammopharmacology | 60.0 | 6 | 0 |
| Mayo Clinic | 49.6 | 4 | 0 |
| Trends in Amplification | 49.6 | 4 | 0 |
| Rice | 49.6 | 4 | 0 |
| Amino Acids | 49.6 | 4 | 0 |
| Algebra Universalis | 42.7 | 3 | 0 |
| Psychological Reports | 42.7 | 3 | 0 |
| The AAPS Journal | 42.7 | 3 | 0 |
| Aequationes Mathematicae | 42.7 | 3 | 0 |
| Neural Development | 42.7 | 3 | 0 |
| The Review of Black Political Economy | 42.7 | 3 | 0 |
| Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance | 40.0 | 0 | 4 |
| Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels | 40.0 | 0 | 4 |
| Juniper (telehealth company) | 40.0 | 0 | 4 |
| WW International | 38.6 | 1 | 1 |
| Nutrisystem | 38.6 | 1 | 1 |
| Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome | 34.5 | 0 | 3 |
| A clinical perspective of obesity, metabolic syndrome and cardiovascular disease | 34.5 | 0 | 3 |
| Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity | 34.5 | 0 | 3 |
| Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome | 34.5 | 0 | 3 |
| Metabolic Syndrome: Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| Statin Therapy Worsens Insulin Sensitivity in Women With Polycystic Ovary Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study | 34.5 | 0 | 3 |
| Limited Weight Loss or Simply No Weight Gain following Lifestyle-Only Intervention Tends to Redistribute Body Fat, to Decrease Lipid Concentrations, and to Improve Parameters of Insulin Sensitivity in Obese Children | 34.5 | 0 | 3 |
| The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females | 34.5 | 0 | 3 |
| A case–control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria | 34.5 | 0 | 3 |
| How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study | 34.5 | 0 | 3 |
| Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Increased gut hormones and insulin sensitivity index following a 3-d intervention with a barley kernel-based product: a randomised cross-over study in healthy middle-aged subjects | 34.5 | 0 | 3 |
| Correlations of Insulin Resistance and Serum Testosterone Levels with LH:FSH Ratio and Oxidative Stress in Women with Functional Ovarian Hyperandrogenism | 34.5 | 0 | 3 |
| Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Association between Metabolic Syndrome and Menstrual Irregularity in Middle-Aged Korean Women | 34.5 | 0 | 3 |
| Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance | 34.5 | 0 | 3 |
| Prevalence of the metabolic syndrome among a racially/ethnically diverse group of U.S. eighth-grade adolescents and associations with fasting insulin and homeostasis model assessment of insulin resistance levels | 34.5 | 0 | 3 |
| Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome | 34.5 | 0 | 3 |
| Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome. | 34.5 | 0 | 3 |
| Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome | 34.5 | 0 | 3 |
| From weight loss to weight gain: appetite changes in major depressive disorder as a mirror into brain-environment interactions | 34.5 | 0 | 3 |
| Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study | 34.5 | 0 | 3 |
| Adiponectin/(FBG × FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Acupuncture treatment for insulin sensitivity of women with polycystic ovary syndrome and insulin resistance: a study protocol for a randomized controlled trial | 34.5 | 0 | 3 |
| Using the Androgen Excess–PCOS Society Criteria to Diagnose Polycystic Ovary Syndrome and the Risk of Metabolic Syndrome in Adolescents | 34.5 | 0 | 3 |
| Extremes of weight gain and weight loss with detailed assessments of energy balance: Illustrative case studies and clinical recommendations | 34.5 | 0 | 3 |
| Polycystic ovary syndrome and metabolic syndrome | 34.5 | 0 | 3 |
| Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome? | 34.5 | 0 | 3 |
| Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism | 34.5 | 0 | 3 |
| Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women | 34.5 | 0 | 3 |
| Could "a body shape index" and "waist to height ratio" predict insulin resistance and metabolic syndrome in polycystic ovary syndrome? | 34.5 | 0 | 3 |
| Metabolic syndrome and insulin resistance in Thai women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Insulin Resistance, Metabolic Syndrome, and Polycystic Ovary Syndrome in Obese Youth | 34.5 | 0 | 3 |
| Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Effects of a community-based weight loss program, jointly established by local government and university faculty, on weight loss and metabolic syndrome components: the Sodegaura Weight Management Study | 34.5 | 0 | 3 |
| Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters | 34.5 | 0 | 3 |
| Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction | 34.5 | 0 | 3 |
| Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. | 34.5 | 0 | 3 |
| Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance | 34.5 | 0 | 3 |
| Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study | 34.5 | 0 | 3 |
| Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels | 34.5 | 0 | 3 |
| Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome | 34.5 | 0 | 3 |
| Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? | 34.5 | 0 | 3 |
| Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance | 34.5 | 0 | 3 |
| Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity | 34.5 | 0 | 3 |
| Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study. | 34.5 | 0 | 3 |
| The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss | 34.5 | 0 | 3 |
| Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome | 34.5 | 0 | 3 |
| Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. | 34.5 | 0 | 3 |
| Menstrual Cycle Alterations during Adolescence: Early Expression of Metabolic Syndrome and Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome | 34.5 | 0 | 3 |
| Total testosterone levels are correlated to metabolic syndrome components | 34.5 | 0 | 3 |
| Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients | 34.5 | 0 | 3 |
| Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women | 34.5 | 0 | 3 |
| Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion | 34.5 | 0 | 3 |
| Maternal and Fetal Outcomes in Preeclampsia: Interrelations Between Insulin Resistance, Aldosterone, Metabolic Syndrome, and Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam | 34.5 | 0 | 3 |
| Androgen levels, insulin sensitivity, and early insulin response in women with polycystic ovary syndrome: a long-term follow-up study | 34.5 | 0 | 3 |
| The Metabolic Effects of Different Weight Loss Diets | 34.5 | 0 | 3 |
| Acupuncture to Treat Insulin Resistance in Women With and Without Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes | 34.5 | 0 | 3 |
| DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health | 34.5 | 0 | 3 |
| The Effect of Acupuncture on Insulin Sensitivity Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| 2-5 Intermittent Caloric Restriction for Weight Loss and Insulin Resistance in HIV-Infected Adults With Features of the Metabolic Syndrome | 34.5 | 0 | 3 |
| The RCT of Acupuncture on PCOS Combined With IR | 34.5 | 0 | 3 |
| Effects of Macronutrients on Hepatic Lipids, Plasma Triglycerides, and Insulin Sensitivity | 34.5 | 0 | 3 |
| Acetylcarnitine and Insulin Sensitivity | 34.5 | 0 | 3 |
| Testosterone Effects on Men With the Metabolic Syndrome | 34.5 | 0 | 3 |
| Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered | 34.5 | 0 | 3 |
| METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT | 34.5 | 0 | 3 |
| Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients | 34.5 | 0 | 3 |
| Smoking is associated with impaired glucose regulation and a decrease in insulin sensitivity and the disposition index in first-degree relatives of type 2 diabetes subjects independently of the presence of metabolic syndrome | 34.5 | 0 | 3 |
| Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels | 34.5 | 0 | 3 |
| Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies | 34.5 | 0 | 3 |
| A prospective pilot study of the effect of acupuncture on insulin sensitivity in women with polycystic ovary syndrome and insulin resistance | 34.5 | 0 | 3 |
| Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women | 34.5 | 0 | 3 |
| Insulin sensitivity improvement with exercise training is mediated by body weight loss in subjects with metabolic syndrome | 34.5 | 0 | 3 |
| Novel Combination of Exercise and Carbohydrate Restriction for Metabolic Health | 34.5 | 0 | 3 |
| Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome | 34.5 | 0 | 3 |
| If insulin resistance lowering therapy is effective in polycystic ovary syndrome patients with androgen excess, why to start with various symptom-oriented treatment forms? | 34.5 | 0 | 3 |
| Effects of resveratrol nanocapsules on the quantitative insulin sensitivity check index in insulin resistance: a study on metabolic syndrome induce mice | 34.5 | 0 | 3 |
| Dissecting Androgen Excess and Metabolic Dysfunction for an Integrated Systems Approach to Polycystic Ovary Syndrome Through the Assessment of Detailed Phenome and Metabolome Data | 34.5 | 0 | 3 |
| Polycystic ovary syndrome; The role of androgen excess in disease pathogenesis and metabolic dysfunction | 34.5 | 0 | 3 |
| Nucleic Acids Research | 33.9 | 2 | 0 |
| Q186756 | 33.9 | 2 | 0 |
| Q229883 | 33.9 | 2 | 0 |
| Administration Science Quarterly | 33.9 | 2 | 0 |
| Bulletin of the Atomic Scientists | 33.9 | 2 | 0 |
| Q1227538 | 33.9 | 2 | 0 |
| In Vitro Cellular & Developmental Biology - Animal | 33.9 | 2 | 0 |
| International Journal of Computer Vision | 33.9 | 2 | 0 |
| Inflammation Research | 33.9 | 2 | 0 |
| Nanoscale Research Letters | 33.9 | 2 | 0 |
| Journal of Cardiovascular Magnetic Resonance | 33.9 | 2 | 0 |
| Journal of Electronic Materials | 33.9 | 2 | 0 |
| Insectes Sociaux | 33.9 | 2 | 0 |
| Memoirs of the New York Botanical Garden | 33.9 | 2 | 0 |
| Journal of the American Society for Mass Spectrometry | 33.9 | 2 | 0 |
| Plasmonics | 33.9 | 2 | 0 |
| Zoomorphology | 33.9 | 2 | 0 |
| Cleveland Clinic | 33.9 | 2 | 0 |
| Acta Applicandae Mathematicae | 33.9 | 2 | 0 |
| Advances in Applied Clifford Algebras | 33.9 | 2 | 0 |
| American Journal of Medical Quality | 33.9 | 2 | 0 |
| American Journal of Men's Health | 33.9 | 2 | 0 |
| American Journal of Translational Research | 33.9 | 2 | 0 |
| Archiv der Mathematik | 33.9 | 2 | 0 |
| Archival Science | 33.9 | 2 | 0 |
| Biomedical Optics Express | 33.9 | 2 | 0 |
| Cellular and Molecular Life Sciences | 33.9 | 2 | 0 |
| Chinese Annals of Mathematics, Series B | 33.9 | 2 | 0 |
| dbSNP | 33.9 | 2 | 0 |
| Ergonomics in Design | 33.9 | 2 | 0 |
| Geometric and Functional Analysis | 33.9 | 2 | 0 |
| Geriatric orthopaedic surgery & rehabilitation | 33.9 | 2 | 0 |
| HSS Journal | 33.9 | 2 | 0 |
| Indian Journal of Psychological Medicine | 33.9 | 2 | 0 |
| JOM | 33.9 | 2 | 0 |
| Journal of Biomolecular Screening | 33.9 | 2 | 0 |
| Journal of Fire Sciences | 33.9 | 2 | 0 |
| Journal of Genetic Counseling | 33.9 | 2 | 0 |
| Journal of Positive Behavior Interventions | 33.9 | 2 | 0 |
| Journal of Psychoeducational Assessment | 33.9 | 2 | 0 |
| Journal of Research in Music Education | 33.9 | 2 | 0 |
| LabCorp | 33.9 | 2 | 0 |
| Proceedings of the Human Factors and Ergonomics Society Annual Meeting | 33.9 | 2 | 0 |
| Western Journal of Medicine | 33.9 | 2 | 0 |
| Simulation & Gaming | 33.9 | 2 | 0 |
| Society | 33.9 | 2 | 0 |
| Stem Cell Reviews and Reports | 33.9 | 2 | 0 |
| The Journal of Supercomputing | 33.9 | 2 | 0 |
| Topics in Early Childhood Special Education | 33.9 | 2 | 0 |
| Trustpilot | 33.9 | 2 | 0 |
| UPDATE: Applications of Research in Music Education | 33.9 | 2 | 0 |
| Ulster Medical Journal | 33.9 | 2 | 0 |
| Violence Against Women | 33.9 | 2 | 0 |
| Zeitschrift fuer Angewandte Mathematik und Physik | 33.9 | 2 | 0 |
| Nonlinear Differential Equations and Applications | 33.9 | 2 | 0 |
| Annals of Combinatorics | 33.9 | 2 | 0 |
| Calcolo | 33.9 | 2 | 0 |
| Complex Analysis and Operator Theory | 33.9 | 2 | 0 |
| Botanica Helvetica | 33.9 | 2 | 0 |
| Journal of Fixed Point Theory and Applications | 33.9 | 2 | 0 |
| Journal of Geometric Analysis | 33.9 | 2 | 0 |
| Positivity | 33.9 | 2 | 0 |
| Revista de la Real Academia de Ciencias Exactas, Físicas y Naturales. Serie A. Matemáticas | 33.9 | 2 | 0 |
| New Labor Forum | 33.9 | 2 | 0 |
| Antitrust Bulletin | 33.9 | 2 | 0 |
| Current Hypertension Reports | 33.9 | 2 | 0 |
| Acta Metallurgica Sinica | 33.9 | 2 | 0 |
| Journal of Geometry | 33.9 | 2 | 0 |
| AAPS PharmSciTech | 33.9 | 2 | 0 |
| Neuropsychiatrie | 33.9 | 2 | 0 |
| Current Topics in Microbiology and Immunology | 33.9 | 2 | 0 |
| Pure and Applied Geophysics | 33.9 | 2 | 0 |
| International Journal of Mental Health Systems | 33.9 | 2 | 0 |
| International Journal of Mental Health and Addiction | 33.9 | 2 | 0 |
| Accreditation and Quality Assurance | 33.9 | 2 | 0 |
| Academic Psychiatry | 33.9 | 2 | 0 |
| Archives of Women's Mental Health | 33.9 | 2 | 0 |
| Computational Complexity | 33.9 | 2 | 0 |
| Journal of Assisted Reproduction and Genetics | 33.9 | 2 | 0 |
| Science and Engineering Ethics | 33.9 | 2 | 0 |
| New Zealand Journal of Educational Studies | 33.9 | 2 | 0 |
| Journal of Physiological Anthropology | 33.9 | 2 | 0 |
| Technology in Cancer Research and Treatment | 33.9 | 2 | 0 |
| The Behavior Analyst | 33.9 | 2 | 0 |
| Iranian Journal of Science and Technology Transaction A: Science | 33.9 | 2 | 0 |
| Mathematics in Computer Science | 33.9 | 2 | 0 |
| Journal of Behavioral Health Services and Research | 33.9 | 2 | 0 |
| Addiction Science and Clinical Practice | 33.9 | 2 | 0 |
| International Journal of Artificial Intelligence in Education | 33.9 | 2 | 0 |
| Learning Disability Quarterly | 33.9 | 2 | 0 |
| American String Teacher | 33.9 | 2 | 0 |
| Journal of Urban Health | 33.9 | 2 | 0 |
| Annals of Biomedical Engineering | 33.9 | 2 | 0 |
| Archivum Immunologiae et Therapiae Experimentalis | 33.9 | 2 | 0 |
| Aquatic Sciences | 33.9 | 2 | 0 |
| Physics in Perspective | 33.9 | 2 | 0 |
| Journal of Mathematical Fluid Mechanics | 33.9 | 2 | 0 |
| Cell Transplantation | 33.9 | 2 | 0 |
| Sports Medicine | 33.9 | 2 | 0 |
| Journal of International Marketing | 33.9 | 2 | 0 |
| Chemoecology | 33.9 | 2 | 0 |
| Software Quality Journal | 33.9 | 2 | 0 |
| North American Archaeologist | 33.9 | 2 | 0 |
| International Journal of Qualitative Methods | 33.9 | 2 | 0 |
| Reproductive Medicine and Biology | 33.9 | 2 | 0 |
| Neurological Sciences | 33.9 | 2 | 0 |
| Psychonomic Bulletin and Review | 33.9 | 2 | 0 |
| International Urology and Nephrology | 33.9 | 2 | 0 |
| Journal of Children's Orthopaedics | 33.9 | 2 | 0 |
| Indian Journal of International Law | 33.9 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 33.9 | 2 | 0 |
| International Journal of Educational Reform | 33.9 | 2 | 0 |
| Environmental Health Insights | 33.9 | 2 | 0 |
| Annals of Hematology | 33.9 | 2 | 0 |
| Structure and Bonding | 33.9 | 2 | 0 |
| Knowledge and Information Systems | 33.9 | 2 | 0 |
| Operations Management Research | 33.9 | 2 | 0 |
| Natural Product Communications | 33.9 | 2 | 0 |
| Fluids and Barriers of the CNS | 33.9 | 2 | 0 |
| UCLA Health System | 33.9 | 2 | 0 |
| Lecture Notes in Mathematics | 33.9 | 2 | 0 |
| Journal on Data Semantics | 33.9 | 2 | 0 |
| Q20641742 | 33.9 | 2 | 0 |
| Zeitschrift für Weiterbildungsforschung - Report | 33.9 | 2 | 0 |
| Current Environmental Health Reports | 33.9 | 2 | 0 |
| SpringerPlus | 33.9 | 2 | 0 |
| Current Psychiatry Reports | 33.9 | 2 | 0 |
| Applied Biosafety | 33.9 | 2 | 0 |
| Hispanic health care international : the official journal of the National Association of Hispanic Nurses | 33.9 | 2 | 0 |
| The Analysis of verbal behavior | 33.9 | 2 | 0 |
| Behavior analysis in practice | 33.9 | 2 | 0 |
| The Journal of clinical and aesthetic dermatology | 33.9 | 2 | 0 |
| Annals of Neurosciences | 33.9 | 2 | 0 |
| Current infectious disease reports | 33.9 | 2 | 0 |
| Alcohol research : current reviews | 33.9 | 2 | 0 |
| Current HIV/AIDS Reports | 33.9 | 2 | 0 |
| Current heart failure reports | 33.9 | 2 | 0 |
| The Ultrasound Journal | 33.9 | 2 | 0 |
| Pulmonary circulation | 33.9 | 2 | 0 |
| Dermato-endocrinology | 33.9 | 2 | 0 |
| British Heart Journal | 33.9 | 2 | 0 |
| United European gastroenterology journal | 33.9 | 2 | 0 |
| The western journal of emergency medicine | 33.9 | 2 | 0 |
| Hepatology international | 33.9 | 2 | 0 |
| Craniomaxillofacial trauma & reconstruction | 33.9 | 2 | 0 |
| Psychiatry | 33.9 | 2 | 0 |
| Mycobiology | 33.9 | 2 | 0 |
| Journal of agricultural ethics | 33.9 | 2 | 0 |
| Simulation & games | 33.9 | 2 | 0 |
| Journal of the American Aging Association | 33.9 | 2 | 0 |
| Magnetic resonance insights | 33.9 | 2 | 0 |
| Biomedical informatics insights | 33.9 | 2 | 0 |
| Clinical Medicine Insights. Cardiology | 33.9 | 2 | 0 |
| Clinical medicine insights. Case reports | 33.9 | 2 | 0 |
| Clinical medicine insights. Pathology | 33.9 | 2 | 0 |
| Nutrition and metabolic insights | 33.9 | 2 | 0 |
| Impulse (Columbia, S.C.) | 33.9 | 2 | 0 |
| Clinical journal of gastroenterology | 33.9 | 2 | 0 |
| Allergy & rhinology (Providence, R.I.) | 33.9 | 2 | 0 |
| i-Perception | 33.9 | 2 | 0 |
| Cardiovascular intervention and therapeutics | 33.9 | 2 | 0 |
| Journal of Central Nervous System Disease | 33.9 | 2 | 0 |
| International journal of multimedia information retrieval | 33.9 | 2 | 0 |
| Urolithiasis | 33.9 | 2 | 0 |
| Network modeling and analysis in health informatics and bioinformatics | 33.9 | 2 | 0 |
| Alpine botany | 33.9 | 2 | 0 |
| Social Network Analysis and Mining | 33.9 | 2 | 0 |
| Medical science educator | 33.9 | 2 | 0 |
| Pastoralism : research, policy and practice | 33.9 | 2 | 0 |
| Life sciences, society and policy | 33.9 | 2 | 0 |
| Boletin de la Sociedad Matematica Mexicana | 33.9 | 2 | 0 |
| Cureus | 33.9 | 2 | 0 |
| Plastic surgery (Oakville, Ont.) | 33.9 | 2 | 0 |
| Journal of experimental orthopaedics | 33.9 | 2 | 0 |
| Sports medicine - open | 33.9 | 2 | 0 |
| Journal of psychosocial rehabilitation and mental health | 33.9 | 2 | 0 |
| Materials for renewable and sustainable energy | 33.9 | 2 | 0 |
| Journal of pseudo-differential operators and applications | 33.9 | 2 | 0 |
| Axios | 33.9 | 2 | 0 |
| Forbes 30 Under 30 | 33.9 | 2 | 0 |
| major depressive disorder | 27.3 | 0 | 2 |
| polyendocrine metabolic ovarian syndrome | 27.3 | 0 | 2 |
| metabolic syndrome | 27.3 | 0 | 2 |
| weight cycling | 27.3 | 0 | 2 |
| Jenny Craig, Inc. | 27.3 | 0 | 2 |
| Weight loss camp | 27.3 | 0 | 2 |
| The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome | 27.3 | 0 | 2 |
| The effects of two workplace weight management programs and weight loss on health care utilization and costs | 27.3 | 0 | 2 |
| Statins for women with polycystic ovary syndrome not actively trying to conceive | 27.3 | 0 | 2 |
| Statins for women with polycystic ovary syndrome not actively trying to conceive | 27.3 | 0 | 2 |
| Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse | 27.3 | 0 | 2 |
| Nesfatin-1 Action in the Brain Increases Insulin Sensitivity Through Akt/AMPK/TORC2 Pathway in Diet-Induced Insulin Resistance | 27.3 | 0 | 2 |
| Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series | 27.3 | 0 | 2 |
| Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis | 27.3 | 0 | 2 |
| Drinking extra water or other non-caloric beverages for promoting weight loss or preventing weight gain | 27.3 | 0 | 2 |
| Genetics of Insulin Resistance and the Metabolic Syndrome | 27.3 | 0 | 2 |
| Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction | 27.3 | 0 | 2 |
| GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity | 27.3 | 0 | 2 |
| Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progress | 27.3 | 0 | 2 |
| Weight Loss Instead of Weight Gain within the Guidelines in Obese Women during Pregnancy: A Systematic Review and Meta-Analyses of Maternal and Infant Outcomes | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance, circadian disruption, antioxidants and pancreatic carcinoma: an overview | 27.3 | 0 | 2 |
| Thyroid Hormones and the Metabolic Syndrome | 27.3 | 0 | 2 |
| Barriers to and Facilitators of Long Term Weight Loss Maintenance in Adult UK People: A Thematic Analysis | 27.3 | 0 | 2 |
| Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome | 27.3 | 0 | 2 |
| Diabetes, insulin resistance, and metabolic syndrome in horses | 27.3 | 0 | 2 |
| Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction | 27.3 | 0 | 2 |
| Bile acids, obesity, and the metabolic syndrome | 27.3 | 0 | 2 |
| A non-traditional model of the metabolic syndrome: the adaptive significance of insulin resistance in fasting-adapted seals | 27.3 | 0 | 2 |
| Dyslipidemia in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis | 27.3 | 0 | 2 |
| Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretation | 27.3 | 0 | 2 |
| Changes in Energy Expenditure with Weight Gain and Weight Loss in Humans | 27.3 | 0 | 2 |
| Nutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndrome | 27.3 | 0 | 2 |
| The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus | 27.3 | 0 | 2 |
| Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects | 27.3 | 0 | 2 |
| Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis | 27.3 | 0 | 2 |
| Testosterone deficiency, insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| P21-activated kinase 2 (PAK2) regulates glucose uptake and insulin sensitivity in neuronal cells | 27.3 | 0 | 2 |
| Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome? | 27.3 | 0 | 2 |
| A major locus for fasting insulin concentrations and insulin resistance on chromosome 6q with strong pleiotropic effects on obesity-related phenotypes in nondiabetic Mexican Americans | 27.3 | 0 | 2 |
| Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction | 27.3 | 0 | 2 |
| New measure of insulin sensitivity predicts cardiovascular disease better than HOMA estimated insulin resistance | 27.3 | 0 | 2 |
| CMHX008, a Novel Peroxisome Proliferator-Activated Receptor γ Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo | 27.3 | 0 | 2 |
| Antidiabetic Property of Symplocos cochinchinensis Is Mediated by Inhibition of Alpha Glucosidase and Enhanced Insulin Sensitivity | 27.3 | 0 | 2 |
| Consumption of clarified grapefruit juice ameliorates high-fat diet induced insulin resistance and weight gain in mice | 27.3 | 0 | 2 |
| Melanin-concentrating hormone induces insulin resistance through a mechanism independent of body weight gain | 27.3 | 0 | 2 |
| Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome | 27.3 | 0 | 2 |
| Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline | 27.3 | 0 | 2 |
| Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome | 27.3 | 0 | 2 |
| Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | 27.3 | 0 | 2 |
| Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity | 27.3 | 0 | 2 |
| Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis | 27.3 | 0 | 2 |
| Feeling the pressure: (patho) physiological mechanisms of weight gain and weight loss in humans | 27.3 | 0 | 2 |
| Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome | 27.3 | 0 | 2 |
| Riboflavin Reduces Pro-Inflammatory Activation of Adipocyte-Macrophage Co-culture. Potential Application of Vitamin B2 Enrichment for Attenuation of Insulin Resistance and Metabolic Syndrome Development | 27.3 | 0 | 2 |
| Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome | 27.3 | 0 | 2 |
| Racial/ethnic and sex differences in the ability of metabolic syndrome criteria to predict elevations in fasting insulin levels in adolescents | 27.3 | 0 | 2 |
| Assessment of Insulin Resistance and Impaired Glucose Tolerance in Lean Women with Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family Study | 27.3 | 0 | 2 |
| Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. | 27.3 | 0 | 2 |
| Insights from the POWER practice-based weight loss trial: a focus group study on the PCP's role in weight management | 27.3 | 0 | 2 |
| Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data? | 27.3 | 0 | 2 |
| Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans | 27.3 | 0 | 2 |
| Impact of body-composition methodology on the composition of weight loss and weight gain | 27.3 | 0 | 2 |
| Equivalent weight loss for weight management programs delivered by phone and clinic | 27.3 | 0 | 2 |
| Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants | 27.3 | 0 | 2 |
| Glucose-induced inhibition of the appetitive brain response to visual food cues in polycystic ovary syndrome patients | 27.3 | 0 | 2 |
| Metabolic syndrome or insulin resistance syndrome. Recent epidemiological data | 27.3 | 0 | 2 |
| Accurate method to estimate insulin resistance from multiple regression models using data of metabolic syndrome and oral glucose tolerance test | 27.3 | 0 | 2 |
| Polycystic ovary syndrome, hyperandrogenism, and insulin resistance | 27.3 | 0 | 2 |
| Potential role of bioavailable curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study | 27.3 | 0 | 2 |
| Insulin sensitivity affects corticolimbic brain responses to visual food cues in polycystic ovary syndrome patients | 27.3 | 0 | 2 |
| Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). | 27.3 | 0 | 2 |
| Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men. | 27.3 | 0 | 2 |
| Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort | 27.3 | 0 | 2 |
| Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance | 27.3 | 0 | 2 |
| Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. | 27.3 | 0 | 2 |
| Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study | 27.3 | 0 | 2 |
| Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease | 27.3 | 0 | 2 |
| Insulin resistance in polycystic ovary syndrome: progress and paradoxes | 27.3 | 0 | 2 |
| Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: evidence and implications | 27.3 | 0 | 2 |
| Insulin resistance and metabolic syndrome in elderly women living in nursing homes. | 27.3 | 0 | 2 |
| Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism | 27.3 | 0 | 2 |
| Fasting insulin, adiponectin, hs-CRP levels, and the components of metabolic syndrome | 27.3 | 0 | 2 |
| Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study | 27.3 | 0 | 2 |
| Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry | 27.3 | 0 | 2 |
| Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance | 27.3 | 0 | 2 |
| Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity | 27.3 | 0 | 2 |
| The Most Popular Smartphone Apps for Weight Loss: A Quality Assessment | 27.3 | 0 | 2 |
| Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients | 27.3 | 0 | 2 |
| Effectiveness of a new dietetic weight management food to achieve weight loss in client-owned obese cats | 27.3 | 0 | 2 |
| Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). | 27.3 | 0 | 2 |
| Genetic variability at the six transmembrane protein of prostate 2 locus and the metabolic syndrome: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study | 27.3 | 0 | 2 |
| Metabolic syndrome and weight gain in adulthood | 27.3 | 0 | 2 |
| Metformin Improves Glucose Effectiveness, Not Insulin Sensitivity: Predicting Treatment Response in Women With Polycystic Ovary Syndrome in an Open-Label, Interventional Study | 27.3 | 0 | 2 |
| Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications | 27.3 | 0 | 2 |
| Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. | 27.3 | 0 | 2 |
| Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents | 27.3 | 0 | 2 |
| Optimal cut‐off point for homeostasis model assessment of insulin resistance to discriminate metabolic syndrome in non‐diabetic Japanese subjects | 27.3 | 0 | 2 |
| Igf-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels, and the metabolic syndrome | 27.3 | 0 | 2 |
| Association between insulin resistance and metabolic syndrome risk factors in Japanese | 27.3 | 0 | 2 |
| Association of vaspin with metabolic syndrome: the pivotal role of insulin resistance | 27.3 | 0 | 2 |
| PGRN Induces Impaired Insulin Sensitivity and Defective Autophagy in Hepatic Insulin Resistance | 27.3 | 0 | 2 |
| Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females | 27.3 | 0 | 2 |
| Hypertriglyceridemia, insulin resistance, and the metabolic syndrome | 27.3 | 0 | 2 |
| One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study | 27.3 | 0 | 2 |
| Circulating Complement-C1q TNF-Related Protein 1 Levels Are Increased in Patients with Type 2 Diabetes and Are Associated with Insulin Sensitivity in Chinese Subjects | 27.3 | 0 | 2 |
| Researching Effective Strategies to Improve Insulin Sensitivity in Children and Teenagers - RESIST. A randomised control trial investigating the effects of two different diets on insulin sensitivity in young people with insulin resistance and/or pre | 27.3 | 0 | 2 |
| Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents | 27.3 | 0 | 2 |
| The use of LeptiCore in reducing fat gain and managing weight loss in patients with metabolic syndrome | 27.3 | 0 | 2 |
| Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance | 27.3 | 0 | 2 |
| Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial | 27.3 | 0 | 2 |
| Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. | 27.3 | 0 | 2 |
| Association of the apolipoprotein b/apolipoprotein a-I ratio, metabolic syndrome components, total cholesterol, and low-density lipoprotein cholesterol with insulin resistance in the population of georgia. | 27.3 | 0 | 2 |
| Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study | 27.3 | 0 | 2 |
| Adiponectin levels and its role in insulin resistance among adult women with metabolic syndrome | 27.3 | 0 | 2 |
| Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome | 27.3 | 0 | 2 |
| Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India | 27.3 | 0 | 2 |
| Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms | 27.3 | 0 | 2 |
| Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Effects of a weight management program delivered by social media on weight and metabolic syndrome risk factors in overweight and obese adults: A randomised controlled trial | 27.3 | 0 | 2 |
| Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome | 27.3 | 0 | 2 |
| Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in a rat model of insulin resistance | 27.3 | 0 | 2 |
| Insulin resistance, polycystic ovary syndrome and metformin | 27.3 | 0 | 2 |
| Insulin sensitivity and brain reward activation in overweight Hispanic girls: a pilot study | 27.3 | 0 | 2 |
| Decoding insulin resistance and metabolic syndrome for promising therapeutic intervention | 27.3 | 0 | 2 |
| Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007) | 27.3 | 0 | 2 |
| Advantages of the single delay model for the assessment of insulin sensitivity from the intravenous glucose tolerance test | 27.3 | 0 | 2 |
| Effects of body weight and alcohol consumption on insulin sensitivity | 27.3 | 0 | 2 |
| DNA hypermethylation of the serotonin receptor type-2A gene is associated with a worse response to a weight loss intervention in subjects with metabolic syndrome | 27.3 | 0 | 2 |
| Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? | 27.3 | 0 | 2 |
| Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance and Fatty liver in obese Iranian children | 27.3 | 0 | 2 |
| Bioactives of Artemisia dracunculus L. enhance insulin sensitivity by modulation of ceramide metabolism in rat skeletal muscle cells | 27.3 | 0 | 2 |
| Associations of prenatal growth with metabolic syndrome, insulin resistance, and nutritional status in Chilean children | 27.3 | 0 | 2 |
| Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Letter: association of vaspin with metabolic syndrome: the pivotal role of insulin resistance (diabetes metab j 2014;38:143-9). | 27.3 | 0 | 2 |
| Response: association of vaspin with metabolic syndrome: the pivotal role of insulin resistance (diabetes metab j 2014;38:143-9) | 27.3 | 0 | 2 |
| Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). | 27.3 | 0 | 2 |
| A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet. | 27.3 | 0 | 2 |
| Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome. | 27.3 | 0 | 2 |
| Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans | 27.3 | 0 | 2 |
| Optimal waist circumference cutoff value reflecting insulin resistance as a diagnostic criterion of metabolic syndrome in a nondiabetic Korean population aged 40 years and over: the Chungju Metabolic Disease Cohort (CMC) study | 27.3 | 0 | 2 |
| Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes | 27.3 | 0 | 2 |
| Short term elevation in dietary protein intake does not worsen insulin resistance or lipids in older adults with metabolic syndrome: a randomized-controlled trial | 27.3 | 0 | 2 |
| Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss. | 27.3 | 0 | 2 |
| Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. | 27.3 | 0 | 2 |
| Vitamin D deficiency in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome). | 27.3 | 0 | 2 |
| Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence | 27.3 | 0 | 2 |
| Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats | 27.3 | 0 | 2 |
| A single nucleotide polymorphism in STK11 influences insulin sensitivity and metformin efficacy in hyperinsulinemic girls with androgen excess. | 27.3 | 0 | 2 |
| Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. | 27.3 | 0 | 2 |
| Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture | 27.3 | 0 | 2 |
| Experimental research Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid | 27.3 | 0 | 2 |
| Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players | 27.3 | 0 | 2 |
| Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI | 27.3 | 0 | 2 |
| Effects of metformin and leuprolide acetate on insulin resistance and testosterone levels in nondiabetic postmenopausal women: a randomized, placebo-controlled trial | 27.3 | 0 | 2 |
| Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome | 27.3 | 0 | 2 |
| Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity | 27.3 | 0 | 2 |
| Tailoring dietary approaches for weight loss | 27.3 | 0 | 2 |
| Aerobic Exercise Plus Weight Loss Improves Insulin Sensitivity and Increases Skeletal Muscle Glycogen Synthase Activity in Older Men | 27.3 | 0 | 2 |
| Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes | 27.3 | 0 | 2 |
| Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes | 27.3 | 0 | 2 |
| Moderate diet-induced weight loss is associated with improved insulin sensitivity in middle-aged healthy obese Korean women | 27.3 | 0 | 2 |
| Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss | 27.3 | 0 | 2 |
| Polycystic ovary syndrome and insulin resistance | 27.3 | 0 | 2 |
| Weight Loss Programs May Have Beneficial or Adverse Effects on Fat Mass and Insulin Sensitivity in Overweight and Obese Black Women | 27.3 | 0 | 2 |
| Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? | 27.3 | 0 | 2 |
| Weight gain following breast cancer diagnosis: Implication and proposed mechanisms | 27.3 | 0 | 2 |
| Dietary weight loss and exercise effects on insulin resistance in postmenopausal women | 27.3 | 0 | 2 |
| Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: a preliminary investigation | 27.3 | 0 | 2 |
| Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training | 27.3 | 0 | 2 |
| Fasting insulin sensitivity indices are not better than routine clinical variables at predicting insulin sensitivity among Black Africans: a clamp study in sub-Saharan Africans. | 27.3 | 0 | 2 |
| Prediction of metabolic syndrome using artificial neural network system based on clinical data including insulin resistance index and serum adiponectin | 27.3 | 0 | 2 |
| CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models | 27.3 | 0 | 2 |
| Taste sensitivity, nutritional status and metabolic syndrome: Implication in weight loss dietary interventions. | 27.3 | 0 | 2 |
| HOMA and Matsuda indices of insulin sensitivity: poor correlation with minimal model-based estimates of insulin sensitivity in longitudinal settings | 27.3 | 0 | 2 |
| A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS). | 27.3 | 0 | 2 |
| Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study | 27.3 | 0 | 2 |
| Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors | 27.3 | 0 | 2 |
| The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study | 27.3 | 0 | 2 |
| Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| The relationship of adiponectin/leptin ratio with homeostasis model assessment insulin resistance index and metabolic syndrome in apparently healthy korean male adults | 27.3 | 0 | 2 |
| Nutritional and Weight Management Behaviors in Low-Income Women Trying to Conceive | 27.3 | 0 | 2 |
| Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association | 27.3 | 0 | 2 |
| Resistant starch improves insulin sensitivity in metabolic syndrome. | 27.3 | 0 | 2 |
| Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome | 27.3 | 0 | 2 |
| N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. | 27.3 | 0 | 2 |
| Intracellular molecular effects of insulin resistance in patients with metabolic syndrome | 27.3 | 0 | 2 |
| Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions | 27.3 | 0 | 2 |
| Insulin resistance and systemic inflammation, but not metabolic syndrome phenotype, predict 9 years mortality in older adults. | 27.3 | 0 | 2 |
| Circulating natriuretic peptide concentrations reflect changes in insulin sensitivity over time in the Diabetes Prevention Program | 27.3 | 0 | 2 |
| Fructose, weight gain, and the insulin resistance syndrome | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance and systemic inflammation as risk factors for reduced lung function in Korean nonsmoking males | 27.3 | 0 | 2 |
| Porcine adiponectin receptor 1 transgene resists high-fat/sucrose diet-induced weight gain, hepatosteatosis and insulin resistance in mice | 27.3 | 0 | 2 |
| Prevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors | 27.3 | 0 | 2 |
| An Overview of the Identification and Management of the Metabolic Syndrome in Chiropractic Practice | 27.3 | 0 | 2 |
| Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women's Health Across the Nation | 27.3 | 0 | 2 |
| Depressive symptoms are associated with fasting insulin resistance in obese youth | 27.3 | 0 | 2 |
| Insulin resistance and metabolic syndrome in prepubertal boys with Klinefelter syndrome | 27.3 | 0 | 2 |
| O-GlcNAc modification is associated with insulin sensitivity in the whole blood of healthy young adult males | 27.3 | 0 | 2 |
| Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance. | 27.3 | 0 | 2 |
| Improvement of Insulin Sensitivity by Isoenergy High Carbohydrate Traditional Asian Diet: A Randomized Controlled Pilot Feasibility Study | 27.3 | 0 | 2 |
| Interventions for weight loss and weight gain prevention among youth: current issues | 27.3 | 0 | 2 |
| Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity | 27.3 | 0 | 2 |
| Polycystic ovary syndrome, androgen excess, and the impact on bone. | 27.3 | 0 | 2 |
| Obesity and weight loss in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Magnesium replacement does not improve insulin resistance in patients with metabolic syndrome: a 12-week randomized double-blind study | 27.3 | 0 | 2 |
| Perseveration augments the effects of cognitive restraint on ad libitum food intake in adults seeking weight loss | 27.3 | 0 | 2 |
| Insulin resistance associated with lower rates of weight gain in Pima Indians | 27.3 | 0 | 2 |
| The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. | 27.3 | 0 | 2 |
| Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome | 27.3 | 0 | 2 |
| Correlation of abdominal adiposity with components of metabolic syndrome, anthropometric parameters and Insulin resistance, in obese and non obese, diabetics and non diabetics: A cross sectional observational study. (Mysore Visceral Adiposity in Dia | 27.3 | 0 | 2 |
| Association of metabolic syndrome with severity of coronary artery disease | 27.3 | 0 | 2 |
| A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys | 27.3 | 0 | 2 |
| Relationship between chronic kidney disease and metabolic syndrome: current perspectives | 27.3 | 0 | 2 |
| Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance. | 27.3 | 0 | 2 |
| Omental adipose tissue gene expression, gene variants, branched-chain amino acids, and their relationship with metabolic syndrome and insulin resistance in humans. | 27.3 | 0 | 2 |
| Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): relationships with adverse outcomes | 27.3 | 0 | 2 |
| Carbohydrate modified diet & insulin sensitizers reduce body weight & modulate metabolic syndrome measures in EMPOWIR (enhance the metabolic profile of women with insulin resistance): a randomized trial of normoglycemic women with midlife weight gai | 27.3 | 0 | 2 |
| Correlation of insulin resistance by various methods with fasting insulin in obese | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance in obese adolescents | 27.3 | 0 | 2 |
| Neck circumference as a new anthropometric indicator for prediction of insulin resistance and components of metabolic syndrome in adolescents: Brazilian Metabolic Syndrome Study. | 27.3 | 0 | 2 |
| Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor | 27.3 | 0 | 2 |
| Genome-wide association study identifies novel loci association with fasting insulin and insulin resistance in African Americans | 27.3 | 0 | 2 |
| Adipose Depots, Not Disease-related Factors, Account for Skeletal Muscle Insulin Sensitivity in Established and Treated Rheumatoid Arthritis | 27.3 | 0 | 2 |
| Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? | 27.3 | 0 | 2 |
| Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort | 27.3 | 0 | 2 |
| Amino acid-induced impairment of insulin sensitivity in healthy and obese rats is reversible | 27.3 | 0 | 2 |
| A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity | 27.3 | 0 | 2 |
| Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques | 27.3 | 0 | 2 |
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | 27.3 | 0 | 2 |
| Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome | 27.3 | 0 | 2 |
| Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome | 27.3 | 0 | 2 |
| Diets High in Protein or Saturated Fat Do Not Affect Insulin Sensitivity or Plasma Concentrations of Lipids and Lipoproteins in Overweight and Obese Adults | 27.3 | 0 | 2 |
| Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy | 27.3 | 0 | 2 |
| Effectiveness of long-term (twelve months) nonsurgical weight loss interventions for obese women with polycystic ovary syndrome: a systematic review | 27.3 | 0 | 2 |
| Effect of a 12-week weight management program on the clinical characteristics and dietary intake of the young obese and the contributing factors to the successful weight loss | 27.3 | 0 | 2 |
| Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women | 27.3 | 0 | 2 |
| Metformin use in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Modulation of age-related insulin sensitivity by VEGF-dependent vascular plasticity in adipose tissues | 27.3 | 0 | 2 |
| Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society | 27.3 | 0 | 2 |
| Visceral obesity and the metabolic syndrome: effects of weight loss | 27.3 | 0 | 2 |
| Obesity-related metabolic dysfunction in dogs: a comparison with human metabolic syndrome | 27.3 | 0 | 2 |
| Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). | 27.3 | 0 | 2 |
| Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice | 27.3 | 0 | 2 |
| Insulin resistance as one of indicators for metabolic syndrome and its associated factors in Indonesian elderly | 27.3 | 0 | 2 |
| Effect of a low-starch/low-dairy diet on fat oxidation in overweight and obese women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| The Relationship Between Serum Adiponectin, Tumor Necrosis Factor-Alpha, Leptin Levels and Insulin Sensitivity in Childhood and Adolescent Obesity: Adiponectin is a Marker of Metabolic Syndrome | 27.3 | 0 | 2 |
| Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance | 27.3 | 0 | 2 |
| Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? | 27.3 | 0 | 2 |
| The association between a low urine pH and the components of metabolic syndrome in the Korean population: Findings based on the 2010 Korea National health and nutrition examination survey | 27.3 | 0 | 2 |
| Relationship between Serum Levels of Body Iron Parameters and Insulin Resistance and Metabolic Syndrome in Korean Children. | 27.3 | 0 | 2 |
| Gestational weight gain and subsequent postpartum weight loss among young, low-income, ethnic minority women | 27.3 | 0 | 2 |
| Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease | 27.3 | 0 | 2 |
| Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study | 27.3 | 0 | 2 |
| Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Associations Between Insulin Resistance, Free Fatty Acids, and Oocyte Quality in Polycystic Ovary Syndrome During In Vitro Fertilization | 27.3 | 0 | 2 |
| The effects of sleeve gastrectomy on hormonal regulation of glucose metabolism in Goto–Kakizaki rats | 27.3 | 0 | 2 |
| Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men. | 27.3 | 0 | 2 |
| Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial | 27.3 | 0 | 2 |
| Liraglutide Increases FGF-21 Activity and Insulin Sensitivity in High Fat Diet and Adiponectin Knockdown Induced Insulin Resistance | 27.3 | 0 | 2 |
| Insulin resistance and fertility in polycystic ovary syndrome | 27.3 | 0 | 2 |
| The effects of abdominal lipectomy in metabolic syndrome components and insulin sensitivity in females: A systematic review and meta-analysis | 27.3 | 0 | 2 |
| Lower bone turnover and relative bone deficits in men with metabolic syndrome: a matter of insulin sensitivity? The European Male Ageing Study. | 27.3 | 0 | 2 |
| Bioactives from Artemisia dracunculus L. enhance insulin sensitivity via modulation of skeletal muscle protein phosphorylation | 27.3 | 0 | 2 |
| Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome | 27.3 | 0 | 2 |
| Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Depression, stress, and weight loss in individuals with metabolic syndrome in SHINE, a DPP translation study. | 27.3 | 0 | 2 |
| Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity? | 27.3 | 0 | 2 |
| Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes | 27.3 | 0 | 2 |
| A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study. | 27.3 | 0 | 2 |
| Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity | 27.3 | 0 | 2 |
| Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus | 27.3 | 0 | 2 |
| Insulin resistance and the metabolic syndrome-a challenge of the new millennium | 27.3 | 0 | 2 |
| Effects of aldosterone on insulin sensitivity and secretion | 27.3 | 0 | 2 |
| Diabetes mellitus, insulin resistance, and metabolic syndrome in HIV-positive patients in South India | 27.3 | 0 | 2 |
| Pioglitazone Improves Cognitive Function via Increasing Insulin Sensitivity and Strengthening Antioxidant Defense System in Fructose-Drinking Insulin Resistance Rats | 27.3 | 0 | 2 |
| Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance | 27.3 | 0 | 2 |
| Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. | 27.3 | 0 | 2 |
| Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation | 27.3 | 0 | 2 |
| Metabolic syndrome in italian obese children and adolescents: stronger association with central fat depot than with insulin sensitivity and birth weight | 27.3 | 0 | 2 |
| Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus | 27.3 | 0 | 2 |
| A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes | 27.3 | 0 | 2 |
| Chronic TNF-α Neutralization Does Not Improve Insulin Resistance or Endothelial Function in “Healthy” Men with Metabolic Syndrome | 27.3 | 0 | 2 |
| Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance | 27.3 | 0 | 2 |
| Effects of caloric intake timing on insulin resistance and hyperandrogenism in lean women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. | 27.3 | 0 | 2 |
| Recurrent Pregnancy Loss in Polycystic Ovary Syndrome: Role of Hyperhomocysteinemia and Insulin Resistance | 27.3 | 0 | 2 |
| MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease | 27.3 | 0 | 2 |
| Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity | 27.3 | 0 | 2 |
| Pre-pubertal children born post-term have reduced insulin sensitivity and other markers of the metabolic syndrome | 27.3 | 0 | 2 |
| Pregnant women's knowledge of weight, weight gain, complications of obesity and weight management strategies in pregnancy | 27.3 | 0 | 2 |
| Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. | 27.3 | 0 | 2 |
| Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| The influence of calcium supplement on body composition, weight loss and insulin resistance in obese adults receiving low calorie diet. | 27.3 | 0 | 2 |
| Excessive 5-year weight gain predicts metabolic syndrome development in healthy middle-aged adults | 27.3 | 0 | 2 |
| Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients | 27.3 | 0 | 2 |
| Shaking Up the System: The Role of Change in Maternal-Adolescent Communication Quality and Adolescent Weight Loss | 27.3 | 0 | 2 |
| IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance | 27.3 | 0 | 2 |
| The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome | 27.3 | 0 | 2 |
| Reduced risk for metabolic syndrome and insulin resistance associated with ovo-lacto-vegetarian behavior in female Buddhists: a case-control study | 27.3 | 0 | 2 |
| Demographic profile, clinical characteristics, motivations and weight loss outcomes of patients in a nonsurgical weight management programme | 27.3 | 0 | 2 |
| Rosiglitazone-Mediated Effects on Skeletal Muscle Gene Expression Correlate with Improvements in Insulin Sensitivity in Individuals with HIV-Insulin Resistance | 27.3 | 0 | 2 |
| Weight loss is not mandatory for exercise-induced effects on health indices in females with metabolic syndrome | 27.3 | 0 | 2 |
| Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes. | 27.3 | 0 | 2 |
| Hepatic insulin resistance, metabolic syndrome and cardiovascular disease | 27.3 | 0 | 2 |
| Incidence of metabolic syndrome over 9 years follow-up; the importance of sex differences in the role of insulin resistance and other risk factors | 27.3 | 0 | 2 |
| Preventing Excessive Weight Gain During Pregnancy and Promoting Postpartum Weight Loss: A Pilot Lifestyle Intervention for Overweight and Obese African American Women | 27.3 | 0 | 2 |
| Adipose tissue monomethyl branched-chain fatty acids and insulin sensitivity: Effects of obesity and weight loss. | 27.3 | 0 | 2 |
| Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction | 27.3 | 0 | 2 |
| The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. | 27.3 | 0 | 2 |
| Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History | 27.3 | 0 | 2 |
| Genetic factors modulate the impact of pubertal androgen excess on insulin sensitivity and fertility | 27.3 | 0 | 2 |
| Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults | 27.3 | 0 | 2 |
| Eating habits of preschool children and the risk of obesity, insulin resistance and metabolic syndrome in adults | 27.3 | 0 | 2 |
| Insulin resistance influences central opioid activity in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age. | 27.3 | 0 | 2 |
| The polycystic ovary syndrome: what does insulin resistance have to do with it? | 27.3 | 0 | 2 |
| A fasting insulin-raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity | 27.3 | 0 | 2 |
| Polycystic ovary syndrome and insulin resistance. | 27.3 | 0 | 2 |
| Insulin resistance and polycystic ovary syndrome | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome | 27.3 | 0 | 2 |
| Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth | 27.3 | 0 | 2 |
| Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment | 27.3 | 0 | 2 |
| Autophagy: A housekeeper in cardiorenal metabolic health and disease | 27.3 | 0 | 2 |
| Association of Mean Platelet Volume With Androgens and Insulin Resistance in Nonobese Patients With Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills | 27.3 | 0 | 2 |
| Endocrine Determinants of Changes in Insulin Sensitivity and Insulin Secretion during a Weight Cycle in Healthy Men | 27.3 | 0 | 2 |
| Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state | 27.3 | 0 | 2 |
| Social embeddedness in an online weight management programme is linked to greater weight loss. | 27.3 | 0 | 2 |
| Beliefs about causes of weight gain, effective weight gain prevention strategies, and barriers to weight management in the Australian population | 27.3 | 0 | 2 |
| Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials | 27.3 | 0 | 2 |
| Study of beta-cell function (by HOMA model) in metabolic syndrome | 27.3 | 0 | 2 |
| CD47 Deficiency Protects Mice From Diet-induced Obesity and Improves Whole Body Glucose Tolerance and Insulin Sensitivity | 27.3 | 0 | 2 |
| Effect of oat intake on glycaemic control and insulin sensitivity: a meta-analysis of randomised controlled trials | 27.3 | 0 | 2 |
| Beneficial Effects of Ethanol Consumption on Insulin Resistance Are Only Applicable to Subjects Without Obesity or Insulin Resistance; Drinking is not Necessarily a Remedy for Metabolic Syndrome | 27.3 | 0 | 2 |
| Weight loss and low-intensity exercise for the treatment of metabolic syndrome in obese postmenopausal women | 27.3 | 0 | 2 |
| Comparison of McAuley/fasting insulin indices with ATP III clinical criteria for the diagnosis of insulin resistance in type 2 diabetes mellitus | 27.3 | 0 | 2 |
| Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome | 27.3 | 0 | 2 |
| Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome | 27.3 | 0 | 2 |
| Androgen excess is the key element in polycystic ovary syndrome | 27.3 | 0 | 2 |
| The importance of insulin resistance in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Fructose-Fed Rhesus Monkeys: A Nonhuman Primate Model of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes | 27.3 | 0 | 2 |
| Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels | 27.3 | 0 | 2 |
| Associations of single nucleotide polymorphisms related to insulin resistance with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Weight gain since menopause and its associations with weight loss maintenance in obese postmenopausal women | 27.3 | 0 | 2 |
| Clinical trial demonstrates exercise following bariatric surgery improves insulin sensitivity | 27.3 | 0 | 2 |
| Hypertension, hyperlipidemia, insulin resistance and obesity: parts of a metabolic syndrome | 27.3 | 0 | 2 |
| The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum | 27.3 | 0 | 2 |
| High sensitivity C-reactive protein, tumor necrosis factor-α, interleukin-6, and vascular cell adhesion molecule-1 levels in Asian Indians with metabolic syndrome and insulin resistance (CURES-105). | 27.3 | 0 | 2 |
| Effect of Probiotic Lactobacillus salivarius UBL S22 and Prebiotic Fructo-oligosaccharide on Serum Lipids, Inflammatory Markers, Insulin Sensitivity, and Gut Bacteria in Healthy Young Volunteers | 27.3 | 0 | 2 |
| Association of Insulin Resistance with Adipocytokine Levels in Patients with Metabolic Syndrome | 27.3 | 0 | 2 |
| Effect of a weight loss program on body composition and metabolic syndrome markers in obese weight cyclers | 27.3 | 0 | 2 |
| Impact of a lifestyle program on vascular insulin resistance in metabolic syndrome subjects: the RESOLVE study. | 27.3 | 0 | 2 |
| Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test | 27.3 | 0 | 2 |
| Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults | 27.3 | 0 | 2 |
| Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010 | 27.3 | 0 | 2 |
| Triglyceride Is a Useful Surrogate Marker for Insulin Resistance in Korean Women with Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS study | 27.3 | 0 | 2 |
| Muscle-Specific Deletion of Comparative Gene Identification-58 (CGI-58) Causes Muscle Steatosis but Improves Insulin Sensitivity in Male Mice | 27.3 | 0 | 2 |
| Mathematical modeling of the insulin signal transduction pathway for prediction of insulin sensitivity from expression data | 27.3 | 0 | 2 |
| Adipose Tissue Dysregulation in Patients with Metabolic Syndrome | 27.3 | 0 | 2 |
| Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice | 27.3 | 0 | 2 |
| Dietary Fat Modifies the Effects of FTO Genotype on Changes in Insulin Sensitivity | 27.3 | 0 | 2 |
| Identification and validation of N-acetyltransferase 2 as an insulin sensitivity gene | 27.3 | 0 | 2 |
| Monogenic forms of insulin resistance: apertures that expose the common metabolic syndrome | 27.3 | 0 | 2 |
| Insulin sensitivity and arterial stiffness in youth with type 1 diabetes: the SEARCH CVD study | 27.3 | 0 | 2 |
| Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study | 27.3 | 0 | 2 |
| Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats | 27.3 | 0 | 2 |
| Ezetimibe combined with standard diet and exercise therapy improves insulin resistance and atherosclerotic markers in patients with metabolic syndrome | 27.3 | 0 | 2 |
| Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction. | 27.3 | 0 | 2 |
| A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study | 27.3 | 0 | 2 |
| Polycystic ovary syndrome (PCOS), insulin resistance and insulin-like growth factors (IGfs)/IGF-binding proteins (IGFBPs) | 27.3 | 0 | 2 |
| Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population--Brazilian Metabolic Syndrome Study (BRAMS). | 27.3 | 0 | 2 |
| Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life | 27.3 | 0 | 2 |
| Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise | 27.3 | 0 | 2 |
| Relationship of resting heart rate and physical activity with insulin sensitivity in a population-based survey | 27.3 | 0 | 2 |
| Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. | 27.3 | 0 | 2 |
| Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis | 27.3 | 0 | 2 |
| The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks | 27.3 | 0 | 2 |
| The Role of Polycystic Ovary Syndrome in Reproductive and Metabolic Health: Overview and Approaches for Treatment | 27.3 | 0 | 2 |
| Using personality as a predictor of diet induced weight loss and weight management | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance in relation to biliary tract cancer and stone risks: a population-based study in Shanghai, China | 27.3 | 0 | 2 |
| Effect of Short Term C PAP Therapy in Obstructive Sleep Apnea Patients with Metabolic Syndrome | 27.3 | 0 | 2 |
| The conundrum of whole foods versus macronutrient composition in assessing effects on insulin sensitivity | 27.3 | 0 | 2 |
| ShRNA-mediated gene silencing of lipoprotein lipase improves insulin sensitivity in L6 skeletal muscle cells | 27.3 | 0 | 2 |
| Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. | 27.3 | 0 | 2 |
| Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study | 27.3 | 0 | 2 |
| Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis | 27.3 | 0 | 2 |
| Biomarkers of insulin sensitivity and insulin resistance: Past, present and future | 27.3 | 0 | 2 |
| Earlier Menarche Is Associated with Lower Insulin Sensitivity and Increased Adiposity in Young Adult Women | 27.3 | 0 | 2 |
| UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity | 27.3 | 0 | 2 |
| Isothiocyanate‐rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice | 27.3 | 0 | 2 |
| Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome. | 27.3 | 0 | 2 |
| Oncostatin M (OSM) protects against cardiac ischaemia/reperfusion injury in diabetic mice by regulating apoptosis, mitochondrial biogenesis and insulin sensitivity | 27.3 | 0 | 2 |
| The potential of phototherapy to reduce body fat, insulin resistance and "metabolic inflexibility" related to obesity in women undergoing weight loss treatment | 27.3 | 0 | 2 |
| The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. | 27.3 | 0 | 2 |
| Glycated Hemoglobin, Fasting Insulin and the Metabolic Syndrome in Males. Cross-Sectional Analyses of the Aragon Workers' Health Study Baseline. | 27.3 | 0 | 2 |
| Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study | 27.3 | 0 | 2 |
| Association of Resistin with Insulin Resistance and Factors of Metabolic Syndrome in North Indians. | 27.3 | 0 | 2 |
| Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus | 27.3 | 0 | 2 |
| Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome | 27.3 | 0 | 2 |
| Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance | 27.3 | 0 | 2 |
| Activated Kupffer cells inhibit insulin sensitivity in obese mice | 27.3 | 0 | 2 |
| The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals | 27.3 | 0 | 2 |
| Hypertension, insulin resistance, and the metabolic syndrome. | 27.3 | 0 | 2 |
| Aerobic exercise training conserves insulin sensitivity for 1 yr following weight loss in overweight women | 27.3 | 0 | 2 |
| Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome | 27.3 | 0 | 2 |
| TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study | 27.3 | 0 | 2 |
| Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance | 27.3 | 0 | 2 |
| Abdominal fat depots associated with insulin resistance and metabolic syndrome risk factors in black African young adults | 27.3 | 0 | 2 |
| A Moderate Low-Carbohydrate Low-Calorie Diet Improves Lipid Profile, Insulin Sensitivity and Adiponectin Expression in Rats | 27.3 | 0 | 2 |
| Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance | 27.3 | 0 | 2 |
| Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study | 27.3 | 0 | 2 |
| Insulin sensitivity index (ISI0, 120) potentially linked to carbon isotopes of breath CO2 for pre-diabetes and type 2 diabetes | 27.3 | 0 | 2 |
| Targets to treat androgen excess in polycystic ovary syndrome. | 27.3 | 0 | 2 |
| Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Insulin resistance and metformin in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Berberine improves insulin sensitivity by inhibiting fat store and adjusting adipokines profile in human preadipocytes and metabolic syndrome patients | 27.3 | 0 | 2 |
| Obesity is associated with insulin resistance and components of the metabolic syndrome in Lebanese adolescents. | 27.3 | 0 | 2 |
| A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome | 27.3 | 0 | 2 |
| Dietary fat, insulin sensitivity and the metabolic syndrome. | 27.3 | 0 | 2 |
| Effect of a 1-week, eucaloric, moderately high-fat diet on peripheral insulin sensitivity in healthy premenopausal women | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals | 27.3 | 0 | 2 |
| Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages. | 27.3 | 0 | 2 |
| Regional Brain Glucose Hypometabolism in Young Women with Polycystic Ovary Syndrome: Possible Link to Mild Insulin Resistance | 27.3 | 0 | 2 |
| Depression and insulin resistance: applications to polycystic ovary syndrome | 27.3 | 0 | 2 |
| A qualitative study exploring why adults with intellectual disabilities and obesity want to lose weight and views of their carers | 27.3 | 0 | 2 |
| Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome | 27.3 | 0 | 2 |
| Polycystic ovary syndrome, obesity and insulin resistance: the new female triad | 27.3 | 0 | 2 |
| Impact of Insulin Resistance on HCV Treatment Response and Impact of HCV Treatment on Insulin Sensitivity Using Direct Measurements of Insulin Action | 27.3 | 0 | 2 |
| The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome | 27.3 | 0 | 2 |
| Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements | 27.3 | 0 | 2 |
| Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma. | 27.3 | 0 | 2 |
| Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome | 27.3 | 0 | 2 |
| Insulin resistance in patients with polycystic ovary syndrome | 27.3 | 0 | 2 |
| The chemical pathology of insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Plasma lipid concentrations in nondiabetic African American adults: associations with insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Neck circumference as a predictor of metabolic syndrome, insulin resistance and low-grade systemic inflammation in children: the ACFIES study. | 27.3 | 0 | 2 |
| Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress | 27.3 | 0 | 2 |
| High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial | 27.3 | 0 | 2 |
| Relation of Osteoprotegerin , Visfatin and Ghrelin to Metabolic Syndrome in Type 2 Diabetic Patients | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance in migraine | 27.3 | 0 | 2 |
| Improved Insulin Sensitivity 3 Months After RYGB Surgery Is Associated With Increased Subcutaneous Adipose Tissue AMPK Activity and Decreased Oxidative Stress | 27.3 | 0 | 2 |
| Lean fish consumption is associated with lower risk of metabolic syndrome: a Norwegian cross sectional study | 27.3 | 0 | 2 |
| Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Heart Rate Variability, Insulin Resistance, and Insulin Sensitivity in Japanese Adults: The Toon Health Study | 27.3 | 0 | 2 |
| The Roles of Adipokines, Proinflammatory Cytokines, and Adipose Tissue Macrophages in Obesity-Associated Insulin Resistance in Modest Obesity and Early Metabolic Dysfunction | 27.3 | 0 | 2 |
| Sensitive and specific markers for insulin resistance, hyperandrogenemia, and inappropriate gonadotrophin secretion in women with polycystic ovary syndrome: a case-control study from Bahrain | 27.3 | 0 | 2 |
| Brain metabolic dysfunction at the core of Alzheimer's disease | 27.3 | 0 | 2 |
| Cerebral Cortical Microvascular Rarefaction in Metabolic Syndrome is Dependent on Insulin Resistance and Loss of Nitric Oxide Bioavailability. | 27.3 | 0 | 2 |
| History of smoking and postcessation weight gain among weight loss surgery candidates | 27.3 | 0 | 2 |
| Does insulin resistance co-exist with glucocorticoid resistance in the metabolic syndrome? Studies comparing skin sensitivity to glucocorticoids in individuals with and without acanthosis nigricans | 27.3 | 0 | 2 |
| Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk | 27.3 | 0 | 2 |
| The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome. | 27.3 | 0 | 2 |
| Increased insulin sensitivity and reduced micro and macro vascular disease induced by 2-deoxy-D-glucose during metabolic syndrome in obese JCR: LA-cp rats. | 27.3 | 0 | 2 |
| Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemia | 27.3 | 0 | 2 |
| Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Circulating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X | 27.3 | 0 | 2 |
| Effects of weight gain and weight loss on regional fat distribution | 27.3 | 0 | 2 |
| The HOMA-Adiponectin (HOMA-AD) Closely Mirrors the HOMA-IR Index in the Screening of Insulin Resistance in the Brazilian Metabolic Syndrome Study (BRAMS). | 27.3 | 0 | 2 |
| Adolescent metabolic syndrome risk is increased with higher infancy weight gain and decreased with longer breast feeding. | 27.3 | 0 | 2 |
| Differential Effects of Nebivolol and Metoprolol on Insulin Sensitivity and Plasminogen Activator Inhibitor in the Metabolic Syndrome | 27.3 | 0 | 2 |
| Plasma vitamin D is associated with fasting insulin and homeostatic model assessment of insulin resistance in young adult males, but not females, of the Jerusalem Perinatal Study | 27.3 | 0 | 2 |
| Insulin sensitivity improvement of fermented Korean Red Ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice | 27.3 | 0 | 2 |
| Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India | 27.3 | 0 | 2 |
| Early Origins of the Metabolic Syndrome: Role of Small Size at Birth, Early Postnatal Weight Gain, and Adult IGF-I | 27.3 | 0 | 2 |
| Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats | 27.3 | 0 | 2 |
| Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome | 27.3 | 0 | 2 |
| Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss | 27.3 | 0 | 2 |
| Sex hormone-binding globulin, oligomenorrhea, polycystic ovary syndrome, and childhood insulin at age 14 years predict metabolic syndrome and class III obesity at age 24 years | 27.3 | 0 | 2 |
| Effect of Selective Mineralocorticoid Receptor Blockade on Flow-Mediated Dilation and Insulin Resistance in Older Adults with Metabolic Syndrome | 27.3 | 0 | 2 |
| Association of Serum Ferritin Levels with Metabolic Syndrome and Insulin Resistance | 27.3 | 0 | 2 |
| Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks. | 27.3 | 0 | 2 |
| Exercise and Weight Loss Improve Muscle Mitochondrial Respiration, Lipid Partitioning, and Insulin Sensitivity After Gastric Bypass Surgery. | 27.3 | 0 | 2 |
| Dietary fat drives whole-body insulin resistance and promotes intestinal inflammation independent of body weight gain | 27.3 | 0 | 2 |
| Administration of progranulin (PGRN) triggers ER stress and impairs insulin sensitivity via PERK-eIF2α-dependent manner | 27.3 | 0 | 2 |
| Association of Sodium Excretion With Metabolic Syndrome, Insulin Resistance, and Body Fat | 27.3 | 0 | 2 |
| Effects of Tai Chi and Walking Exercises on Weight Loss, Metabolic Syndrome Parameters, and Bone Mineral Density: A Cluster Randomized Controlled Trial | 27.3 | 0 | 2 |
| GLUT4 content decreases along with insulin resistance and high levels of inflammatory markers in rats with metabolic syndrome | 27.3 | 0 | 2 |
| Absence of association between −286C>A>T polymorphism in the CRP gene and metabolic syndrome in Iranian pediatric | 27.3 | 0 | 2 |
| Association of Metabolic Syndrome with the Adiponectin to Homeostasis Model Assessment of Insulin Resistance Ratio | 27.3 | 0 | 2 |
| Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women | 27.3 | 0 | 2 |
| Exercise-Induced Lowering of Fetuin-A May Increase Hepatic Insulin Sensitivity | 27.3 | 0 | 2 |
| Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings | 27.3 | 0 | 2 |
| Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? | 27.3 | 0 | 2 |
| Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country | 27.3 | 0 | 2 |
| A review: which dietary plan is best for your patients seeking weight loss and sustained weight management? | 27.3 | 0 | 2 |
| Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population. | 27.3 | 0 | 2 |
| Lipid therapy for cardiovascular disease with insulin resistance, diabetes, or the metabolic syndrome | 27.3 | 0 | 2 |
| Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study | 27.3 | 0 | 2 |
| Niacin plus Simvastatin Reduces Coronary Stenosis Progression Among Patients with Metabolic Syndrome Despite a Modest Increase in Insulin Resistance: A Subgroup Analysis of the HDL-Atherosclerosis Treatment Study (HATS). | 27.3 | 0 | 2 |
| Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus | 27.3 | 0 | 2 |
| Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHI | 27.3 | 0 | 2 |
| Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people | 27.3 | 0 | 2 |
| Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults | 27.3 | 0 | 2 |
| Association between Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) and Components of Metabolic Syndrome in Young Chinese Men | 27.3 | 0 | 2 |
| Long-term Impact of Childhood Adiposity on Adult Metabolic Syndrome Is Modified by Insulin Resistance: The Bogalusa Heart Study | 27.3 | 0 | 2 |
| Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events. | 27.3 | 0 | 2 |
| Which insulin resistance-based definition of metabolic syndrome has superior diagnostic value in detection of poor health-related quality of life? Cross-sectional findings from Tehran Lipid and Glucose Study. | 27.3 | 0 | 2 |
| The Effect of Green Tea Extract on Reproductive Improvement in Estradiol Valerate-Induced Polycystic Ovarian Syndrome in Rat | 27.3 | 0 | 2 |
| Fish consumption, insulin sensitivity and beta-cell function in the Insulin Resistance Atherosclerosis Study (IRAS) | 27.3 | 0 | 2 |
| The Influence of Sleep Disordered Breathing on Weight Loss in a National Weight Management Program | 27.3 | 0 | 2 |
| Is insulin resistance the cause of the metabolic syndrome? | 27.3 | 0 | 2 |
| The metabolic syndrome, hyperlipidemia, and insulin resistance | 27.3 | 0 | 2 |
| Protective effect of rosiglitazone, quercetin, and their combination on fructose-induced metabolic syndrome in rats | 27.3 | 0 | 2 |
| Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. | 27.3 | 0 | 2 |
| Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease | 27.3 | 0 | 2 |
| Indices of Central and Peripheral Obesity; Anthropometric Measurements and Laboratory Parameters of Metabolic Syndrome and Thyroid Function | 27.3 | 0 | 2 |
| Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies | 27.3 | 0 | 2 |
| Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study | 27.3 | 0 | 2 |
| Transient hypoxia reprograms differentiating adipocytes for enhanced insulin sensitivity and triglyceride accumulation | 27.3 | 0 | 2 |
| Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease | 27.3 | 0 | 2 |
| Metabolic syndrome in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Correction of insulin resistance and the metabolic syndrome. | 27.3 | 0 | 2 |
| The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism. | 27.3 | 0 | 2 |
| Insulin resistance: trigger or concomitant factor in the metabolic syndrome. | 27.3 | 0 | 2 |
| Effect of weight loss, independent of change in diet composition, on apolipoprotein AI kinetic in men with metabolic syndrome. | 27.3 | 0 | 2 |
| Michael Smith, md: Treat the Underlying Causes of Weight Gain to Facilitate Successful Weight Loss | 27.3 | 0 | 2 |
| Protective effects of berberine on high fat-induced kidney damage by increasing serum adiponectin and promoting insulin sensitivity | 27.3 | 0 | 2 |
| The metabolic syndrome in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Relationship of insulin sensitivity, insulin secretion, and adiposity with insulin clearance in a multiethnic population: the insulin Resistance Atherosclerosis study | 27.3 | 0 | 2 |
| The metabolic syndrome. Beyond the insulin resistance syndrome. | 27.3 | 0 | 2 |
| A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants | 27.3 | 0 | 2 |
| Molecular mechanisms of insulin resistance in polycystic ovary syndrome | 27.3 | 0 | 2 |
| The importance of palmitoleic acid to adipocyte insulin resistance and whole-body insulin sensitivity in type 1 diabetes | 27.3 | 0 | 2 |
| Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. | 27.3 | 0 | 2 |
| Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy | 27.3 | 0 | 2 |
| Use of the triglyceride to HDL cholesterol ratio for assessing insulin sensitivity in overweight and obese children in rural Appalachia | 27.3 | 0 | 2 |
| Analysis of the degree of insulin resistance in post menopausal women by using skin temperature measurements and fasting insulin and fasting glucose levels: a case control study | 27.3 | 0 | 2 |
| Atherogenic dyslipidemia associated with metabolic syndrome and insulin resistance | 27.3 | 0 | 2 |
| Change in fatty liver status and 5-year risk of incident metabolic syndrome: a retrospective cohort study | 27.3 | 0 | 2 |
| Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies. | 27.3 | 0 | 2 |
| Genetic causal attributions for weight status and weight loss during a behavioral weight gain prevention intervention. | 27.3 | 0 | 2 |
| Insulin sensitivity affects propensity to obesity in an ethnic-specific manner: results from two controlled weight loss intervention studies | 27.3 | 0 | 2 |
| Different Impacts of Metabolic Syndrome Components on Insulin Resistance in Type 2 Diabetes | 27.3 | 0 | 2 |
| Low serum 25(OH)D levels are assocıated to hıgher BMI and metabolic syndrome parameters in adult subjects in Turkey | 27.3 | 0 | 2 |
| Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity? | 27.3 | 0 | 2 |
| Dietary composition and weight loss: can we individualize dietary prescriptions according to insulin sensitivity or secretion status? | 27.3 | 0 | 2 |
| Obesity and Insulin Resistance Are the Main Determinants of Postprandial Lipoprotein Dysmetabolism in Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Weight loss is associated with plasma free amino acid alterations in subjects with metabolic syndrome | 27.3 | 0 | 2 |
| Association between metabolic syndrome and premicroalbuminuria among Iranian women with Polycystic Ovary Syndrome: a case control study. | 27.3 | 0 | 2 |
| Exercise training with weight loss and either a high- or low-glycemic index diet reduces metabolic syndrome severity in older adults. | 27.3 | 0 | 2 |
| Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome? | 27.3 | 0 | 2 |
| Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? | 27.3 | 0 | 2 |
| Stress in women: metabolic syndrome and polycystic ovary syndrome | 27.3 | 0 | 2 |
| Sleep is increased by weight gain and decreased by weight loss in mice. | 27.3 | 0 | 2 |
| Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran. | 27.3 | 0 | 2 |
| Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. | 27.3 | 0 | 2 |
| Obesity, metabolic syndrome, and insulin resistance in urban high school students of minority race/ethnicity | 27.3 | 0 | 2 |
| Effects of clinically significant weight loss with exercise training on insulin resistance and cardiometabolic adaptations | 27.3 | 0 | 2 |
| Effects of nutrition education on weight gain prevention: a randomized controlled trial | 27.3 | 0 | 2 |
| Insulin resistance, metabolic syndrome and endothelial dysfunction | 27.3 | 0 | 2 |
| Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Can early weight loss, eating behaviors and socioeconomic factors predict successful weight loss at 12- and 24-months in adolescents with obesity and insulin resistance participating in a randomised controlled trial? | 27.3 | 0 | 2 |
| Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey | 27.3 | 0 | 2 |
| Examining metabolic syndrome definitions in overweight Hispanic youth: a focus on insulin resistance | 27.3 | 0 | 2 |
| Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome? | 27.3 | 0 | 2 |
| Eight weeks of supplementation with a multi-ingredient weight loss product enhances body composition, reduces hip and waist girth, and increases energy levels in overweight men and women | 27.3 | 0 | 2 |
| Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss | 27.3 | 0 | 2 |
| Identification of Differentially Expressed MicroRNAs in the Ovary of Polycystic Ovary Syndrome with Hyperandrogenism and Insulin Resistance | 27.3 | 0 | 2 |
| Polycystic ovary syndrome: a component of metabolic syndrome? | 27.3 | 0 | 2 |
| Strategies for assessment of botanical action on metabolic syndrome in the mouse and evidence for a genotype-specific effect of Russian tarragon in the regulation of insulin sensitivity | 27.3 | 0 | 2 |
| Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women | 27.3 | 0 | 2 |
| Berberine improves mesenteric artery insulin sensitivity through up‐regulating insulin receptor‐mediated signalling in diabetic rats | 27.3 | 0 | 2 |
| Short-term weight loss attenuates local tissue inflammation and improves insulin sensitivity without affecting adipose inflammation in obese mice | 27.3 | 0 | 2 |
| Supplementation of Lactobacillus plantarum K68 and Fruit-Vegetable Ferment along with High Fat-Fructose Diet Attenuates Metabolic Syndrome in Rats with Insulin Resistance. | 27.3 | 0 | 2 |
| Identifying subjects with insulin resistance by using the modified criteria of metabolic syndrome | 27.3 | 0 | 2 |
| Apple polyphenol extract improves insulin sensitivity in vitro and in vivo in animal models of insulin resistance. | 27.3 | 0 | 2 |
| Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology | 27.3 | 0 | 2 |
| Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. | 27.3 | 0 | 2 |
| Effects of Diet Composition and Insulin Resistance Status on Plasma Lipid Levels in a Weight Loss Intervention in Women | 27.3 | 0 | 2 |
| Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss | 27.3 | 0 | 2 |
| Involvement of the pancreatic renin-angiotensin system in insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents | 27.3 | 0 | 2 |
| Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis | 27.3 | 0 | 2 |
| The management of insulin resistance in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Cutting Calories and TXNIP From the Skeletal Muscle to Restore Insulin Sensitivity | 27.3 | 0 | 2 |
| Biochemical Assessment of Bone Health in Working Obese Egyptian Females with Metabolic Syndrome; the Effect of Weight Loss by Natural Dietary Therapies. | 27.3 | 0 | 2 |
| Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance | 27.3 | 0 | 2 |
| Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus | 27.3 | 0 | 2 |
| Diagnosis of insulin resistance in hypertensive patients by the metabolic syndrome: AHA vs. IDF definitions | 27.3 | 0 | 2 |
| Targets to treat metabolic syndrome in polycystic ovary syndrome | 27.3 | 0 | 2 |
| Birth Size, Early Life Weight Gain, and Midchildhood Cardiometabolic Health | 27.3 | 0 | 2 |
| Polycystic ovary syndrome patients with high BMI tend to have functional disorders of androgen excess: a prospective study | 27.3 | 0 | 2 |
| Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation | 27.3 | 0 | 2 |
| Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance. | 27.3 | 0 | 2 |
| Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. | 27.3 | 0 | 2 |
| AMPK, insulin resistance, and the metabolic syndrome | 27.3 | 0 | 2 |
| Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients | 27.3 | 0 | 2 |
| C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study | 27.3 | 0 | 2 |
| Insulin resistance as the underlying cause for the metabolic syndrome | 27.3 | 0 | 2 |
| Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes? | 27.3 | 0 | 2 |
| Impact of Insulin Resistance on Insulin-Like Growth Factor-1/Insulin Like Growth Factor-Binding Protein-3 Axis and on Early Weight Gain in Small for Gestational Age Infants | 27.3 | 0 | 2 |
| Apolipoprotein B, apolipoprotein A-I, insulin resistance and the metabolic syndrome | 27.3 | 0 | 2 |
| Zingiber mioga reduces weight gain, insulin resistance and hepatic gluconeogenesis in diet-induced obese mice | 27.3 | 0 | 2 |
| Prenatal androgen excess negatively impacts body fat distribution in a nonhuman primate model of polycystic ovary syndrome | 27.3 | 0 | 2 |
| Association of common genetic variants with diabetes and metabolic syndrome related traits in the Arizona Insulin Resistance registry: a focus on Mexican American families in the Southwest | 27.3 | 0 | 2 |
| Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic | 27.3 | 0 | 2 |
| miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance | 27.3 | 0 | 2 |
| Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society. | 27.3 | 0 | 2 |
| Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial | 27.3 | 0 | 2 |
| Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. | 27.3 | 0 | 2 |
| Effect of berberine on insulin resistance in women with polycystic ovary syndrome: study protocol for a randomized multicenter controlled trial | 27.3 | 0 | 2 |
| Antipsychotic Drugs Opposite to Metabolic Risk: Neurotransmitters, Neurohormonal and Pharmacogenetic Mechanisms Underlying with Weight Gain and Metabolic Syndrome | 27.3 | 0 | 2 |
| Fermented Red Ginseng Potentiates Improvement of Metabolic Dysfunction in Metabolic Syndrome Rat Models | 27.3 | 0 | 2 |
| Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review. | 27.3 | 0 | 2 |
| Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women? | 27.3 | 0 | 2 |
| Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society | 27.3 | 0 | 2 |
| Polycystic ovary syndrome (PCOS) and other androgen excess-related conditions: can changes in dietary intake make a difference? | 27.3 | 0 | 2 |
| Changes in Weight Loss, Health Behaviors, and Intentions among 400 Participants Who Dropped out from an Insurance-Sponsored, Community-Based Weight Management Program | 27.3 | 0 | 2 |
| The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. | 27.3 | 0 | 2 |
| Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome | 27.3 | 0 | 2 |
| Effects of perilipin (PLIN) gene variation on metabolic syndrome risk and weight loss in obese children and adolescents | 27.3 | 0 | 2 |
| Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients | 27.3 | 0 | 2 |
| Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta | 27.3 | 0 | 2 |
| Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood | 27.3 | 0 | 2 |
| Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance | 27.3 | 0 | 2 |
| Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus | 27.3 | 0 | 2 |
| Lipoprotein particle distribution and size, insulin resistance, and metabolic syndrome in Alaska Eskimos: the GOCADAN study | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance: perioperative considerations | 27.3 | 0 | 2 |
| Aerobic exercise + weight loss decreases skeletal muscle myostatin expression and improves insulin sensitivity in older adults | 27.3 | 0 | 2 |
| Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss | 27.3 | 0 | 2 |
| Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease | 27.3 | 0 | 2 |
| Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice | 27.3 | 0 | 2 |
| Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome - a randomized study (SYSDIET). | 27.3 | 0 | 2 |
| Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248HFEC282Y Homozygotes Identified by Population Screening in the HEIRS Study | 27.3 | 0 | 2 |
| Skeletal muscle metabolic dysfunction in obesity and metabolic syndrome | 27.3 | 0 | 2 |
| Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome | 27.3 | 0 | 2 |
| Improvements in insulin sensitivity after aerobic exercise and weight loss in older women with a history of gestational diabetes and type 2 diabetes mellitus | 27.3 | 0 | 2 |
| Sex may modify the effects of macronutrient intake on metabolic syndrome and insulin resistance in American Indians: the strong heart study | 27.3 | 0 | 2 |
| Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study | 27.3 | 0 | 2 |
| The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance | 27.3 | 0 | 2 |
| Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals | 27.3 | 0 | 2 |
| Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome | 27.3 | 0 | 2 |
| Transgenic overexpression of VEGF-C induces weight gain and insulin resistance in mice | 27.3 | 0 | 2 |
| Insulin resistance and the metabolic syndrome. | 27.3 | 0 | 2 |
| Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboons | 27.3 | 0 | 2 |
| Metabolic syndrome and pre‐diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways | 27.3 | 0 | 2 |
| Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference | 27.3 | 0 | 2 |
| Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls | 27.3 | 0 | 2 |
| The Relationship of Metabolic Syndrome Traits with Beta-Cell Function and Insulin Sensitivity by Oral Minimal Model Assessment in South Asian and European Families Residing in the Netherlands | 27.3 | 0 | 2 |
| Intraperitoneal Injection of Clodronate Liposomes Eliminates Visceral Adipose Macrophages and Blocks High-fat Diet-induced Weight Gain and Development of Insulin Resistance | 27.3 | 0 | 2 |
| Deletion of the gene encoding G0/G 1 switch protein 2 (G0s2) alleviates high-fat-diet-induced weight gain and insulin resistance, and promotes browning of white adipose tissue in mice. | 27.3 | 0 | 2 |
| Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? | 27.3 | 0 | 2 |
| Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects | 27.3 | 0 | 2 |
| Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Systematic review of clinical studies related to pork intake and metabolic syndrome or its components | 27.3 | 0 | 2 |
| Impact of clinical characteristics of individual metabolic syndrome on the severity of insulin resistance in Chinese adults | 27.3 | 0 | 2 |
| Blood-Based Indicators of Insulin Resistance and Metabolic Syndrome in Bottlenose Dolphins (Tursiops truncatus) | 27.3 | 0 | 2 |
| Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity | 27.3 | 0 | 2 |
| Proteolytic receptor cleavage in the pathogenesis of blood rheology and co-morbidities in metabolic syndrome. Early forms of autodigestion | 27.3 | 0 | 2 |
| Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications. | 27.3 | 0 | 2 |
| Low-grade chronic inflammation in the relationship between insulin sensitivity and cardiovascular disease (RISC) population: associations with insulin resistance and cardiometabolic risk profile | 27.3 | 0 | 2 |
| Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. | 27.3 | 0 | 2 |
| Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome | 27.3 | 0 | 2 |
| PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. | 27.3 | 0 | 2 |
| Components of metabolic syndrome and 5‐year change in insulin clearance – the Insulin Resistance Atherosclerosis Study | 27.3 | 0 | 2 |
| The metabolic syndrome--from insulin resistance to obesity and diabetes | 27.3 | 0 | 2 |
| Effects of ACE Inhibitors on Insulin Resistance and Lipid Profile in Children with Metabolic Syndrome | 27.3 | 0 | 2 |
| Threshold for Improvement in Insulin Sensitivity with Adolescent Weight Loss | 27.3 | 0 | 2 |
| Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. | 27.3 | 0 | 2 |
| Effect on Insulin-Stimulated Release of D-Chiro-Inositol-Containing Inositolphosphoglycan Mediator during Weight Loss in Obese Women with and without Polycystic Ovary Syndrome. | 27.3 | 0 | 2 |
| The difference in correlation between insulin resistance index and chronic inflammation in type 2 diabetes with and without metabolic syndrome | 27.3 | 0 | 2 |
| The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report | 27.3 | 0 | 2 |
| Adipose tissue and metabolic syndrome: too much, too little or neither | 27.3 | 0 | 2 |
| Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss | 27.3 | 0 | 2 |
| Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults | 27.3 | 0 | 2 |
| Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania | 27.3 | 0 | 2 |
| Capsule Commentary on Weinstock et al., Weight Loss Success in Metabolic Syndrome by Telephone Interventions: Results from the SHINE Study | 27.3 | 0 | 2 |
| Weight loss success in metabolic syndrome by telephone interventions: results from the SHINE Study. | 27.3 | 0 | 2 |
| Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index | 27.3 | 0 | 2 |
| Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers | 27.3 | 0 | 2 |
| Metabolic syndrome resolution in children and adolescents after 10 weeks of weight loss | 27.3 | 0 | 2 |
| Loss of ovarian function in the VCD mouse-model of menopause leads to insulin resistance and a rapid progression into the metabolic syndrome. | 27.3 | 0 | 2 |
| Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. | 27.3 | 0 | 2 |
| Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? | 27.3 | 0 | 2 |
| Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. | 27.3 | 0 | 2 |
| The Midwest Exercise Trial for the Prevention of Weight Regain: MET POWeR | 27.3 | 0 | 2 |
| The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents | 27.3 | 0 | 2 |
| Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects | 27.3 | 0 | 2 |
| Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity | 27.3 | 0 | 2 |
| The effect of berberine on insulin resistance in women with polycystic ovary syndrome: detailed statistical analysis plan (SAP) for a multicenter randomized controlled trial | 27.3 | 0 | 2 |
| Circulating irisin in relation to insulin resistance and the metabolic syndrome. | 27.3 | 0 | 2 |
| Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran | 27.3 | 0 | 2 |
| An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome | 27.3 | 0 | 2 |
| Low birth weight and early weight gain in the metabolic syndrome: consequences for infant nutrition | 27.3 | 0 | 2 |
| A Trypsin Inhibitor from Tamarind Reduces Food Intake and Improves Inflammatory Status in Rats with Metabolic Syndrome Regardless of Weight Loss | 27.3 | 0 | 2 |
| Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals | 27.3 | 0 | 2 |
| High fasting insulin levels and insulin resistance may be linked to idiopathic recurrent pregnancy loss: a case-control study | 27.3 | 0 | 2 |
| Evaluation of attendance and weight loss in an intensive weight management clinic compared to standard dietetic care | 27.3 | 0 | 2 |
| Deep analyses of the associations of a series of biomarkers with insulin resistance, metabolic syndrome, and diabetes risk in nondiabetic middle-aged and elderly individuals: results from a Chinese community-based study | 27.3 | 0 | 2 |
| Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome | 27.3 | 0 | 2 |